3James P. Thomas,Kendra D. Tutsch,James F. Cleary,Howard H. Bailey,Rhoda Arzoomanian,Dona Alberti,Kris Simon,Chris Feierabend,Kimberly Binger,Rebecca Marnocha,Amy Dresen,George Wilding. Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol[J] 2002,Cancer Chemotherapy and Pharmacology(6):465～472
3Laird AD,Christensen JG,Li G,et al.SU6668 inhibits Flk-1/KDR and PDGFR beta in vivo,resulting in rapid apoptosis of tumor vasculature and tumor regression in mice.FASEB J,2002,16:681-690.
4Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis.A new significant and independent prognostic factor in early-stage breast carcinoma.J Natl Cancer Inst,1992,84:1875-1887.
5Xiong HQ,Herbst R,Faria SC,et al.A phase Ⅰ surrogate endpoint study of SU6668 in patients with solid tumors.Invest New Drugs,2004,2:459-466.
6Garofalo A,Naumova E,Manenti L,et al.The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.Clin Cancer Res,2003,9:3476-3485.
7Laird AD,Vajkoczy P,Shawver LK,et al.SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.Cancer Res,2000,60:4152-4160.
8Marzola P,Degrassi A,Calderan L,et al.In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model.Clin Cancer Res,2004,10:739-750.
1Rvla JK, Lee WJ, Lee KH, et al. SK-7041, a new histone deacetylase inhibitor, induces G2-M ceil cycle arrest and apoptosis in pancreatic cancer cell lines [ J ] . Cancer Lett, 2006, 237(1): 143-154.
2Muto Y, Ninomya M, Fuiki H. Present status of research on cancer chemoprevention in Japan [J]. Jpn J Clin Oncol,1990, 20(3): 219-220.
3Luo JZ, Luo L. Ameircan ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in culture beta cells [ J ] . Evid Based Complement Alternat Med, 2006, 3(3): 365-372.
4Makinen K, Loimus S, Haklaa T, et al. Tumour suppressor protein (p53), apoptosis inhibiting protein (bcl-2) and proliferating cell nuclear antigen expressions in a rat pancreatic tumour model [ J ] . Anticancer Res, 2007, 27(1A): 23-26.
5Ahsan H, Reagna S, Breur J, el al. Snaguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC- 3 cells via modulations in Bcl-2 family proteins [ J ] . Cancer Lett, 2007, 249(2): 198-208.
6Hou Q, Cymbalyuk E, Hsu SC, et al. Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome C release and Bax regulation [ J ] . Apoptosis 2003, 8(6): 617- 629.
7Rvla JK,Lee WJ,Lee KH,et al. SK-7041 ,a new historic deacety- lase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. Cancer Lett, 2006,237 ( 1 ) : 143- 154.
8Lu Q,Zhang P,Zhang X,et al. Experiment study of the anti- cancer mechanism of tanshinone IIA against human breast canc- er. Int J Mol Med,2009,24(6) :773-780.
9Wang X, Wei Y, Yuan S, et al. Potential anticancer activity of tan- shlnone IIA against human breast cancer. Int J Cancer,2005,116 (5) :799-807.
10Liu JJ, Zhang Y, Lin D J, et al. Tanshinone tIA inhibits leukemia THP-1 cell growth by induction of apoptosis. Oncol Rep,2009,21 (4) :1075-1081.
